David T. Long

David T. Long

Auto-generated profile, based on publicly available information

David T. Long

Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Cell
Verified
Journal Article
Closed access
YFYu Vincent Fu
Yu Vincent Fu
HYHasan Yardimci
Hasan Yardimci
DLDavid T Long
David T Long
THThe Vinh Ho
The Vinh Ho
AGAngelo Guainazzi
Angelo Guainazzi
JWJohannes C Walter
Johannes C Walter

1 May 2014 in Molecular Cell
Verified
Journal Article
Closed access
DDDaisy Klein Douwel
Daisy Klein Douwel
RBRick A.C.M. Boonen
Rick A.C.M. Boonen
DLDavid T. Long
David T. Long
ASAnna A. Szypowska
Anna A. Szypowska
MRMarkus Räschle
Markus Räschle
PKPuck Knipscheer
Puck Knipscheer

1 May 2015 in Science
Verified
Journal Article
Closed access
PDF file
MRMarkus Räschle
Markus Räschle
GSGodelieve Smeenk
Godelieve Smeenk
RHRebecca K. Hansen
Rebecca K. Hansen
TTTikira Temu
Tikira Temu
YOYasuyoshi Oka
Yasuyoshi Oka
MMMatthias Mann
Matthias Mann
Uncrossing covalently linked DNA strands: DNA interstrand cross-links (ICLs) covalently link the two strands of the double helix. ICL mutations are difficult to repair, because the two DNA strands cannot be separated and so one strand cannot be used as a template to repair the other. Räschle et al. developed a mass spectrometry–based method to systematically analyze a time series of all the proteins recruited to repair ICLs in Xenopus egg extracts. They found many of the known factors required for ICL repair. They also found a number of new factors, two of which define a new repair pathway for ICL mutations. Science , this issue 10.1126/science.1253671

1 July 2011 in Science
Verified
Journal Article
Closed access
PDF file
DLDavid T. Long
David T. Long
MRMarkus Räschle
Markus Räschle
VJVladimir Joukov
Vladimir Joukov
JWJohannes C. Walter
Johannes C. Walter
DNA interstrand cross-links (ICLs) are toxic DNA lesions whose repair in S phase of eukaryotic cells is incompletely understood. In Xenopus egg extracts, ICL repair is initiated when two replication forks converge on the lesion. Dual incisions then create a DNA double-strand break (DSB) in one sister chromatid, whereas lesion bypass restores the other sister. We report that the broken sister chromatid is repaired via RAD51-dependent strand invasion into the regenerated sister. Recombination acts downstream of FANCI-FANCD2, yet RAD51 binds ICL-stalled replication forks independently of FANCI-FANCD2 and before DSB formation. Our results elucidate the functional link between the Fanconi anemia pathway and the recombination machinery during ICL repair. In addition, they demonstrate the complete repair of a DSB via homologous recombination in vitro.

1 April 2013 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
JPJonghoon Park
Jonghoon Park
DLDavid T. Long
David T. Long
KLKyung Yong Lee
Kyung Yong Lee
TATarek Abbas
Tarek Abbas
ESEtsuko Shibata
Etsuko Shibata
ADAnindya Dutta
Anindya Dutta
The minichromosome maintenance protein homologs MCM8 and MCM9 have previously been implicated in DNA replication elongation and prereplication complex (pre-RC) formation, respectively. We found that MCM8 and MCM9 physically associate with each other and that MCM8 is required for the stability of MCM9 protein in mammalian cells. Depletion of MCM8 or MCM9 in human cancer cells or the loss of function MCM9 mutation in mouse embryo fibroblasts sensitizes cells to the DNA interstrand cross-linking (ICL) agent cisplatin. Consistent with a role in the repair of ICLs by homologous recombination (HR), knockdown of MCM8 or MCM9 significantly reduces HR repair efficiency. Chromatin immunoprecipitation analysis using human DR-GFP cells or Xenopus egg extract demonstrated that MCM8 and MCM9 proteins are rapidly recruited to DNA damage sites and promote RAD51 recruitment. Thus, these two metazoan-specific MCM homologs are new components of HR and may represent novel targets for treating cancer in combination with DNA cross-linking agents.

1 October 2014 in Molecular Cell
Verified
Journal Article
Closed access
DLDavid T. Long
David T. Long
VJVladimir Joukov
Vladimir Joukov
MBMagda Budzowska
Magda Budzowska
JWJohannes C. Walter
Johannes C. Walter